Vol 4, No 4 (December 2013): Journal of Gastrointestinal Oncology

Editorials

Intensifying local radiotherapy for pancreatic cancer—who benefits and how do we select them?
Sunil Krishnan, Mediha Ahmad
New possibilities and potential benefits for local control in locally recurrent pancreatic cancer
Shane Lloyd, Bryan W. Chang

Original Articles

Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutions
Aaron T. Wild, Susan M. Hiniker, Daniel T. Chang, Phuoc T. Tran, Mouen A. Khashab, Maneesha R. Limaye, Daniel A. Laheru, Dung T. Le, Rachit Kumar, Jonathan S. Pai, Blaire Hargens, Andrew B. Sharabi, Eun Ji Shin, Lei Zheng, Timothy M. Pawlik, Christopher L. Wolfgang, Albert C. Koong, Joseph M. Herman
Preoperative chemoradiation and IOERT for unresectable or borderline resectable pancreas cancer
Jonathan B. Ashman, Adyr A. Moss, William G. Rule, Matthew G. Callister, K. Sudhakar Reddy, David C. Mulligan, Joseph M. Collins, Giovanni De Petris, Leonard L. Gunderson, Mitesh Borad
Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer
Gary Y. Yang, Nadia K. Malik, Rameela Chandrasekhar, Wen-Wee Ma, Leayn Flaherty, Renuka Iyer, Boris Kuvshinoff, John Gibbs, Gregory Wilding, Graham Warren, Kilian Salerno May
Nab-paclitaxel monotherapy in refractory pancreatic adenocarcinoma
Parvin F. Peddi, May Cho, Jian Wang, Feng Gao, Andrea Wang-Gillam
Proton therapy may allow for comprehensive elective nodal coverage for patients receiving neoadjuvant radiotherapy for localized pancreatic head cancers
Richard Y. Lee, Romaine C. Nichols Jr, Soon N. Huh, Meng W. Ho, Zuofeng Li, Robert Zaiden, Ziad T. Awad, Bestoun Ahmed, Bradfors S. Hoppe
Neoadjuvant hyperfractionated-accelerated radiotherapy with concomitant chemotherapy in esophageal cancer: phase II study
Sezer Saglam, Alptekin Arifoglu, Esra Kaytan Saglam, Fatih Tunca, Oktar Asoglu, Gulgun Engin, Sumer Yamaner
Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal and hepatic metastases: a case-control study
Frans F. Duraj, Peter H. Cashin
Mismatch repair protein expression in colorectal cancer
Elrasheid A. H. Kheirelseid, Nicola Miller, Kah Hoong Chang, Catherine Curran, Emer Hennessey, Margaret Sheehan, Michael J Kerin

Review Article

Diet and supplements and their impact on colorectal cancer
Marinos Pericleous, Dalvinder Mandair, Martyn E. Caplin

Case Reports

A case report of trastuzumab dose in gastric cancer
Chrisann Kyi, Manish A. Shah
Intrapancreatic accessory spleen presenting as a pancreatic mass
Simon J. Lehtinen, Christine M. Schammel, Michael Devane, Steven D. Trocha
Metachronous pancreatic metastasis of an ovarian serous papillary adenocarcinoma after 8 years
Andrea Anderloni, Marco Ballarè, Michela Pagliarulo, Marco Orsello, Antonio Ramponi, Mario Del Piano
Cholangiocarcinoma: treatment with sorafenib extended life expectancy to greater than four years
Hareesha Rao Chakunta, Ravi Sunderkrishnan, Mark A. Kaplan, Reza Mostofi

Letter to the Editor

RE: Upper gastrointestinal complications associated with gemcitabine-concurrent proton radiotherapy for inoperable pancreatic cancer. J Gastroenterol. 2013; (E-pub only).
R. Charles Nichols, Jr, Bradford S. Hoppe